Here, we report the first case of a translocation in a patient with newly diagnosed chronic-phase CML harboring a novel e4a2 <i>BCR::ABL1</i> fusion gene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.